Sponsor franchise

Drugs Made In America

Named principals: Lynn Stockwell

Grouping established from the sponsor entity and issuer names.

Vehicles launched

2 still live

Capital raised

$647M

aggregate IPO proceeds

Trust under management

$661M

in live vehicles

Deals closed

0 liquidated

Completion rate

—

nothing resolved yet

Vehicles

Every SPAC attributed to Drugs Made In America, newest IPO first.

Watch	SPAC	Status	Trust	Per share	IPO	Deadline	Sponsor / target
	Drugs Made In America Acquisition II Corp.DMII · Nasdaq	Searching	$514M	$10.28	Sep 2025	—	Healthcare
	Drugs Made In America Acquisition Corp.DMAA · Nasdaq	Announced	$147M	$10.71	Jan 2025	Apr 29, 2026lapsed	Healthcare